Evidence map›Paper›PMID 25053784›Full record

ArticlemBio2014

Propionibacterium-produced coproporphyrin III induces Staphylococcus aureus aggregation and biofilm formation.

Michael S Wollenberg, Jan Claesen, Isabel F Escapa, Kelly L Aldridge, Michael A Fischbach, Katherine P Lemon

Open access · goldAbstract read
In one paragraph

Article in mBio, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 118 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Alterations of the skin microbiome in HIV infection with pruritus.Frontiers in cellular and infection microbiology · 2026
    Article
  9. Review
  10. The Role of Skin Dysbiosis and Quorum Sensing in Atopic Dermatitis.JID innovations : skin science from molecules to population health · 2025
    Review
  11. Review
  12. Article
  13. Article
  14. Heme alters biofilm formation inMicrobiology spectrum · 2025
    Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Michael S WollenbergDepartment of Microbiology, The Forsyth Institute, Cambridge, Massachusetts, USA Department of Oral Medicine, Infection & Immunity, Harvard School of Dental Medicine, Boston, Massachusetts, USA.
Jan ClaesenDepartment of Bioengineering and Therapeutic Sciences and the California Institute for Quantitative Biosciences, University of California San Francisco, San Francisco, California, USA.
Isabel F Escapa
Kelly L AldridgeDepartment of Microbiology, The Forsyth Institute, Cambridge, Massachusetts, USA.
Michael A FischbachDepartment of Bioengineering and Therapeutic Sciences and the California Institute for Quantitative Biosciences, University of California San Francisco, San Francisco, California, USA.
Katherine P Lemonklemon@forsyth.org.
Harvard University · USQB3 · USBoston Children's Hospital · US

Funding

Antibiotics from nose and throat commensals that impact pathogen colonizationR01AI101018 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI FISCHBACH, MICHAEL ANDREW, LEMON, KATHERINE PAIGE · 2012 to 2021
$4.4M
FORSYTH POSTDOCTORAL TRAINING IN ORAL HEALTH RESEARCHT32DE007327 · NIDCR · FORSYTH INSTITUTE · PI VAN DYKE, THOMAS ELLIOTT · 2001 to 2015
$3.5M
Identifying and characterizing small molecules from the human microbiomeDP2OD007290 · OD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FISCHBACH, MICHAEL ANDREW · 2010 to 2010
$2.3M
The Forsyth Core Center for Discovery at the Host-Biofilm InterfaceP30DE020751 · NIDCR · ADA FORSYTH INSTITUTE, INC. · PI SMITH, DANIEL JAMES · 2009 to 2010
$1.8M
NIAID NIH HHS AI101018NIAID NIH HHS R01 AI101018NIDCR NIH HHS DE020751NIDCR NIH HHS P30 DE020751NIDCR NIH HHS T32 DE007327NIH HHS DP2 OD007290NIH HHS OD007290
6 · The paper itself

Abstract

The majority of bacteria detected in the nostril microbiota of most healthy adults belong to three genera: Propionibacterium, Corynebacterium, and Staphylococcus. Among these staphylococci is the medically important bacterium Staphylococcus aureus. Almost nothing is known about interspecies interactions among bacteria in the nostrils. We observed that crude extracts of cell-free conditioned medium from Propionibacterium spp. induce S. aureus aggregation in culture. Bioassay-guided fractionation implicated coproporphyrin III (CIII), the most abundant extracellular porphyrin produced by human-associated Propionibacterium spp., as a cause of S. aureus aggregation. This aggregation response depended on the CIII dose and occurred during early stationary-phase growth, and a low pH (~4 to 6) was necessary but was not sufficient for its induction. Additionally, CIII induced plasma-independent S. aureus biofilm development on an abiotic surface in multiple S. aureus strains. In strain UAMS-1, CIII stimulation of biofilm depended on sarA, a key biofilm regulator. This study is one of the first demonstrations of a small-molecule-mediated interaction among medically relevant members of the nostril microbiota and the first description of a role for CIII in bacterial interspecies interactions. Our results indicate that CIII may be an important mediator of S. aureus aggregation and/or biofilm formation in the nostril or other sites inhabited by Propionibacterium spp. and S. aureus. Importance: Very little is known about interspecies interactions among the bacteria that inhabit the adult nostril, including Staphylococcus aureus, a potential pathogen that colonizes about a quarter of adults. We demonstrated that coproporphyrin III (CIII), a diffusible small molecule excreted by nostril- and skin-associated Propionibacterium spp., induces S. aureus aggregation in a manner dependent on dose, growth phase, and pH. CIII also induces S. aureus to form a plasma-independent surface-attached biofilm. This report is the first description of a role for CIII in bacterial interspecies interactions at any human body site and a novel demonstration that nostril microbiota physiology is influenced by small-molecule-mediated interactions.

Indexed as

BiofilmsChromatography, High Pressure LiquidCoproporphyrinsCulture Media, ConditionedPropionibacteriumStaphylococcus aureuscoproporphyrin IIICoproporphyrinsCulture Media, Conditioned

Identifiers

PMID25053784
PMCPMC4120196
OpenAlexW2023164381

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.